Glenmark gets India's nod for making favipiravir for COVID-19 treatment
The Mumbai-based company said the approval was part of India`s accelerated approval process and the drug was meant for "restricted emergency use," meaning patients must sign their consent before being treated by the drug.
Jun 20, 2020, 08:28 AM IST